Log in

600829 HPGC Renmintongtai Pharmaceutical Corporation SSE · China

HPGC Renmintongtai Pharmaceutical (600829) news

HPGC Renmintongtai Pharmaceutical Corporation is a public biotech or pharmaceutical company listed on SSE under the ticker 600829, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest HPGC Renmintongtai Pharmaceutical news

We have not published a story on HPGC Renmintongtai Pharmaceutical yet. When there is news, it will appear here.

Questions about HPGC Renmintongtai Pharmaceutical

What is the ticker symbol of HPGC Renmintongtai Pharmaceutical?

HPGC Renmintongtai Pharmaceutical Corporation trades under the ticker 600829 on SSE.

Where is HPGC Renmintongtai Pharmaceutical listed?

HPGC Renmintongtai Pharmaceutical Corporation is listed on SSE.

Which country or territory is HPGC Renmintongtai Pharmaceutical listed under?

Our directory records HPGC Renmintongtai Pharmaceutical Corporation under China.

What does HPGC Renmintongtai Pharmaceutical do?

Our directory classifies HPGC Renmintongtai Pharmaceutical Corporation as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of HPGC Renmintongtai Pharmaceutical?

The ISIN recorded for HPGC Renmintongtai Pharmaceutical Corporation is CNE000000G05.

Does aibio.space cover HPGC Renmintongtai Pharmaceutical?

aibio.space lists HPGC Renmintongtai Pharmaceutical Corporation among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to HPGC Renmintongtai Pharmaceutical?

Companies in our directory listed in the same country and business area as HPGC Renmintongtai Pharmaceutical: Shanghai Shenqi Pharmaceutical Investment Management Co., Transcenta Holding, Joincare Pharmaceutical Group Industry Co., Jiangxi Fushine Pharmaceutical Co., Guizhou Bailing Group Pharmaceutical Co., Acrobiosystems Co..

Investor discussion: HPGC Renmintongtai Pharmaceutical

Members talk about HPGC Renmintongtai Pharmaceutical (600829). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:600829 on TradingView.

Listing details

HPGC Renmintongtai Pharmaceutical Corporation is a public biotech or pharmaceutical company listed on SSE under the ticker 600829, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
HPGC Renmintongtai Pharmaceutical Corporation
Ticker
600829
Listing
SSE
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
CNE000000G05
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.